OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS
M&A Transactions
M&A Transaction Chart
Viridian publishes weekly data on M&A transactions in the Cannabis/CBD/Psychedelic industries. This data includes information about the buyer and seller (public/private, state/country location), deal size, deal structure (cash, stock, earn-out), pricing, share information, and deal implied valuation.
Week ended 02/24/2023
Week ended 02/24/2023
This Section is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
M&A Transactions Commentary
Week ended 02/24/2023
The Largest Closed M&A Deal of the Week:
- On February 21, 2023, Irwin Naturals (IWIN: CSE)(IWINF: OTC), a premier nutraceutical formulator that recently entered the psychedelic market through its acquisition of Braxia Scientific, announced the closing of its acquisition of Serenety Health, LLC, one of the leading ketamine clinics in Louisville, Kentucky.
- The total consideration and terms of the transaction were not disclosed except that it would include upfront, deferred, and contingent consideration.
- The transaction brings the number of clinics under the Irwin Naturals Emergence umbrella to 22 pro forma.
Week ended 02/24/2023
This is the MA basic
Additional content is available to Premium and Enterprise users. Please purchase a higher tier membership to see more.
Viridian publishes weekly insights on the M&A landscape in the Cannabis/CBD/Psychedelic industries. These insights typically highlight the most interesting/meaningful M&A transactions for that week, and commentary on market conditions, M&A deal structures, target regions for acquirers, and industry sectors ripe for consolidation.